Last reviewed 2026-04-20 · How we verify

Tetrafinol (carbon tetrachloride)

unknown active

Tetrafinol (generic name: carbon tetrachloride) is a carbon tetrachloride drug. It is currently in unknown development.

Carbon tetrachloride works by binding to the Cytochrome P450 2E1 enzyme, potentially inhibiting its activity.

Tetrafinol, also known as carbon tetrachloride, is a small molecule that targets the Cytochrome P450 2E1 enzyme. However, there is limited information available on this compound, suggesting it may not be a commercially available or FDA-approved medication. As a result, its commercial status, approved indications, and pharmacokinetic properties are unknown. Further research is needed to understand its potential therapeutic applications and safety profile. Unfortunately, this information is not available in the provided facts.

At a glance

Generic name	carbon tetrachloride
Drug class	carbon tetrachloride
Target	Cytochrome P450 2E1
Therapeutic area	Metabolic
Phase	unknown

Mechanism of action

Imagine your body has a factory that breaks down toxic substances. Cytochrome P450 2E1 is a key worker in this factory. Carbon tetrachloride is like a tool that can temporarily stop this worker from doing its job, which may help reduce the damage caused by toxic substances.

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Study of Oral Uremic Toxin Absorbent/Probiotics to Modulate Systemic Inflammation and Retard the Progression of Chronic Kidney Disease in Patients With Diabetes. (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Tetrafinol CI brief — competitive landscape report
Tetrafinol updates RSS · CI watch RSS
portfolio CI

Frequently asked questions about Tetrafinol

What is Tetrafinol?

Tetrafinol (carbon tetrachloride) is a carbon tetrachloride drug.

How does Tetrafinol work?

Carbon tetrachloride works by binding to the Cytochrome P450 2E1 enzyme, potentially inhibiting its activity.

What is the generic name of Tetrafinol?

carbon tetrachloride is the generic (nonproprietary) name of Tetrafinol.

What drug class is Tetrafinol in?

Tetrafinol belongs to the carbon tetrachloride class. See all carbon tetrachloride drugs at /class/carbon-tetrachloride.

What development phase is Tetrafinol in?

Tetrafinol is in unknown.

What does Tetrafinol target?

Tetrafinol targets Cytochrome P450 2E1 and is a carbon tetrachloride.

Drug class: All carbon tetrachloride drugs
Target: All drugs targeting Cytochrome P450 2E1
Manufacturer: — full pipeline
Therapeutic area: All drugs in Metabolic

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing